|
Kotskaya A.V., Kudinov V.I., Terentyev V.P., Kobzeva N.D.
Prevalence and possibilities for early diagnosis of cardiovascular autonomous neuropathy in patients with coronary artery disease and type 2 diabetes
|
№1 / 2019
|
|
Pereverzeva K.G., Loukianov M.M., Martsevich S.Yu., Andreenko E.Yu., Zagrebelnyy A.V., Boytsov S.A., Yakushin S.S.
Long-term adherence to treatment in patients with ischemic heart disease and myocardial infarction in comparison with other cardiovascular diseases
|
№1 / 2019
|
|
V.V. Cheltzov
If it is possible to prevent metabolic remodelling: possibilities of trimetazidine use
|
№7 / 2017
|
|
E.O. Taratukhin
Clopidogrel – historical and modern base of antiplatelet therapy in acute coronary syndrome
|
№6 / 2017
|
|
B.B. Fishman, A.I. Khorochevskaya, V.V. Zurabov, А.V. Savolyuk, N.О. Zhbanova, S.SH. Butrimova, I.V. Prozorova, D.A. Shamiladze, O.U.Lole
Modelling of parameters lipid a spectrum depending on age and size of an index of weight of a body at patients with clinical forms of ischemic illness of heart
|
№6 / 2017
|
|
L.B. Lazebnik, I.A. Komissarenko, S.V. Levchenko
Сardiological problems in gastroenterological patients
|
№3 / 2017
|
|
A.R. Volkova, S.V. Dora, O.A. Berkovich, O.D. Dygun, Ye.V. Volkova, Ye.N. Ostroukhova
Subclinical hypothyroidism – new cardiovascular risk factor
|
№6 / 2016
|
|
Ye.S. Levitskaya, M.M. Batyushin
Predicting the risk of development of cerebral stroke in patients in the remote period after myocardial revascularization taking into account renal risk factors
|
№5 / 2016
|
|
M.Ye. Statsenko, S.V. Turkina, I.A. Tyshchenko, S.V. Fabritskaya
Application of Mildronate in patients with comorbidity: focus on cardioneurology
|
№5 / 2016
|
|
V.V. Cheltsov, A.I. Martynov, Yu.Sh. Gushchina, T.S. Illarionova, E.A. Korovyakova
Metabolic therapy in chronic heart failure
|
№4 / 2016
|
|
A.I. Martynov, Ye.V. Akatova, O.P. Nikolin, I.V. Urlayeva
Type A behavior as a risk factor of acute coronary syndrom
|
№1 / 2016
|
|
G.L. Yurenev, A.N. Kazyulin, T.V. Yureneva-Tkhorzhevskaya
The influence of acid-suppressive therapy on the clinical course of ischemic heart disease with refractory pain syndrome in the chest
|
№2 / 2015
|
Русский
